{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,6]],"date-time":"2026-05-06T21:23:00Z","timestamp":1778102580105,"version":"3.51.4"},"reference-count":43,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2018,7,1]],"date-time":"2018-07-01T00:00:00Z","timestamp":1530403200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2018,7,1]],"date-time":"2018-07-01T00:00:00Z","timestamp":1530403200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jaci-inpractice.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Journal of Allergy and Clinical Immunology: In Practice"],"published-print":{"date-parts":[[2018,7]]},"DOI":"10.1016\/j.jaip.2017.09.004","type":"journal-article","created":{"date-parts":[[2017,11,1]],"date-time":"2017-11-01T03:30:40Z","timestamp":1509507040000},"page":"1287-1296.e1","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":66,"title":["The Combined Utility of Ex\u00a0Vivo IFN-\u03b3 Release Enzyme-Linked ImmunoSpot Assay and In\u00a0Vivo Skin\u00a0Testing in Patients with Antibiotic-Associated Severe Cutaneous Adverse Reactions"],"prefix":"10.1016","volume":"6","author":[{"given":"Jason A.","family":"Trubiano","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kaija","family":"Strautins","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alec J.","family":"Redwood","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rebecca","family":"Pavlos","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Katherine C.","family":"Konvinse","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ar Kar","family":"Aung","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Monica A.","family":"Slavin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Karin A.","family":"Thursky","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M. Lindsay","family":"Grayson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Elizabeth J.","family":"Phillips","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.jaip.2017.09.004_bib1","doi-asserted-by":"crossref","first-page":"1187","DOI":"10.1016\/j.jaip.2016.04.026","article-title":"A\u00a0comparative analysis between antibiotic- and nonantibiotic-associated delayed cutaneous adverse drug reactions","volume":"4","author":"Trubiano","year":"2016","journal-title":"J\u00a0Allergy Clin Immunol Pract"},{"key":"10.1016\/j.jaip.2017.09.004_bib2","doi-asserted-by":"crossref","first-page":"1377","DOI":"10.1093\/cid\/ciu126","article-title":"Severe cutaneous adverse reactions related to systemic antibiotics","volume":"58","author":"Lin","year":"2014","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.jaip.2017.09.004_bib3","doi-asserted-by":"crossref","first-page":"896","DOI":"10.1038\/clpt.2011.79","article-title":"Phenotype standardization for immune-mediated drug-induced skin injury","volume":"89","author":"Pirmohamed","year":"2011","journal-title":"Clin Pharmacol Ther"},{"key":"10.1016\/j.jaip.2017.09.004_bib4","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1111\/bjd.12125","article-title":"A\u00a0multicentre study to determine the value and safety of drug patch tests for the three main classes of severe cutaneous adverse drug reactions","volume":"168","author":"Barbaud","year":"2013","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.jaip.2017.09.004_bib5","first-page":"781","article-title":"Reactivation of skin lesions after patch testing to investigate drug rash with eosinophilia and systemic symptoms (DRESS) syndrome","volume":"107","author":"Cordoba","year":"2016","journal-title":"Actas Dermosifiliogr"},{"key":"10.1016\/j.jaip.2017.09.004_bib6","doi-asserted-by":"crossref","first-page":"1181","DOI":"10.1001\/archderm.139.9.1181","article-title":"A\u00a0systemic reaction to patch testing for the evaluation of acute generalized exanthematous pustulosis","volume":"139","author":"Mashiah","year":"2003","journal-title":"Arch Dermatol"},{"key":"10.1016\/j.jaip.2017.09.004_bib7","doi-asserted-by":"crossref","first-page":"1413","DOI":"10.1016\/j.jaci.2012.05.042","article-title":"Amikacin-induced drug reaction with eosinophilia and systemic symptoms syndrome: delayed skin test and ELISPOT assay results allow the identification of the culprit drug","volume":"130","author":"Bensaid","year":"2012","journal-title":"J\u00a0Allergy Clin Immunol"},{"key":"10.1016\/j.jaip.2017.09.004_bib8","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1124\/jpet.111.190900","article-title":"Characterization of the antigen specificity of T-cell clones from piperacillin-hypersensitive patients with cystic fibrosis","volume":"341","author":"El-Ghaiesh","year":"2012","journal-title":"J\u00a0Pharmacol Exp Ther"},{"key":"10.1016\/j.jaip.2017.09.004_bib9","doi-asserted-by":"crossref","first-page":"534","DOI":"10.1111\/j.1398-9995.2008.01674.x","article-title":"Detection and quantification of drug-specific T cells in penicillin allergy","volume":"64","author":"Rozieres","year":"2009","journal-title":"Allergy"},{"key":"10.1016\/j.jaip.2017.09.004_bib10","doi-asserted-by":"crossref","first-page":"1027","DOI":"10.1111\/cea.12145","article-title":"In\u00a0vitro drug causality assessment in Stevens-Johnson syndrome\u2014alternatives for lymphocyte transformation test","volume":"43","author":"Porebski","year":"2013","journal-title":"Clin Exp Allergy"},{"key":"10.1016\/j.jaip.2017.09.004_bib11","doi-asserted-by":"crossref","first-page":"823","DOI":"10.1016\/j.jaip.2016.09.043","article-title":"Drug-specific upregulation of CD137 on CD8+ T cells aids in the diagnosis of multiple antibiotic toxic epidermal necrolysis","volume":"5","author":"Trubiano","year":"2017","journal-title":"J\u00a0Allergy Clin Immunol Pract"},{"key":"10.1016\/j.jaip.2017.09.004_bib12","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1016\/j.jdermsci.2017.03.007","article-title":"Novel interferon-gamma enzyme-linked immunoSpot assay using activated cells for identifying hypersensitivity-inducing drug culprits","volume":"86","author":"Kato","year":"2017","journal-title":"J\u00a0Dermatol Sci"},{"key":"10.1016\/j.jaip.2017.09.004_bib13","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1038\/clpt.1981.154","article-title":"A\u00a0method for estimating the probability of adverse drug reactions","volume":"30","author":"Naranjo","year":"1981","journal-title":"Clin Pharmacol Ther"},{"key":"10.1016\/j.jaip.2017.09.004_bib14","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1038\/clpt.2009.252","article-title":"ALDEN, an algorithm for assessment of drug causality in Stevens-Johnson syndrome and toxic epidermal necrolysis: comparison with case-control analysis","volume":"88","author":"Sassolas","year":"2010","journal-title":"Clin Pharmacol Ther"},{"key":"10.1016\/j.jaip.2017.09.004_bib15","doi-asserted-by":"crossref","first-page":"1071","DOI":"10.1111\/bjd.12501","article-title":"Drug reaction with eosinophilia and systemic symptoms (DRESS): an original multisystem adverse drug reaction: results from the prospective RegiSCAR study","volume":"169","author":"Kardaun","year":"2013","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.jaip.2017.09.004_bib16","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1034\/j.1600-0560.2001.028003113.x","article-title":"Acute generalized exanthematous pustulosis (AGEP)\u2013a clinical reaction pattern","volume":"28","author":"Sidoroff","year":"2001","journal-title":"J\u00a0Cutan Pathol"},{"key":"10.1016\/j.jaip.2017.09.004_bib17","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1046\/j.0105-4538.2001.00001.x-i8","article-title":"General considerations for skin test procedures in the diagnosis of drug hypersensitivity","volume":"57","author":"Brockow","year":"2002","journal-title":"Allergy"},{"key":"10.1016\/j.jaip.2017.09.004_bib18","doi-asserted-by":"crossref","first-page":"702","DOI":"10.1111\/all.12142","article-title":"Skin test concentrations for systemically administered drugs \u2013 an ENDA\/EAACI Drug Allergy Interest Group position paper","volume":"68","author":"Brockow","year":"2013","journal-title":"Allergy"},{"key":"10.1016\/j.jaip.2017.09.004_bib19","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1034\/j.1600-0536.2001.450601.x","article-title":"European Society of Contact Dermatitis. Guidelines for performing skin tests with drugs in the investigation of cutaneous adverse drug reactions","volume":"45","author":"Barbaud","year":"2001","journal-title":"Contact Dermatitis"},{"key":"10.1016\/j.jaip.2017.09.004_bib20","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1038\/icb.2011.34","article-title":"High-avidity, high-IFNgamma-producing CD8 T-cell responses following immune selection during HIV-1 infection","volume":"90","author":"Keane","year":"2012","journal-title":"Immunol Cell Biol"},{"key":"10.1016\/j.jaip.2017.09.004_bib21","series-title":"The Sanford Guide to Antimicrobial Therapy","author":"Gilbert","year":"2017"},{"key":"10.1016\/j.jaip.2017.09.004_bib22","doi-asserted-by":"crossref","first-page":"1891","DOI":"10.1097\/QAD.0000000000000345","article-title":"HLA Class I restricted CD8+ and class II restricted CD4+ T cells are implicated in the pathogenesis of nevirapine hypersensitivity","volume":"28","author":"Keane","year":"2014","journal-title":"AIDS"},{"key":"10.1016\/j.jaip.2017.09.004_bib23","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1097\/QCO.0000000000000323","article-title":"Old dog begging for new tricks: current practices and future directions in the diagnosis of delayed antimicrobial hypersensitivity","volume":"29","author":"Konvinse","year":"2016","journal-title":"Curr Opin Infect Dis"},{"key":"10.1016\/j.jaip.2017.09.004_bib24","first-page":"15","article-title":"Testing for drug hypersensitivity syndromes","volume":"34","author":"Rive","year":"2013","journal-title":"Clin Biochem Rev"},{"key":"10.1016\/j.jaip.2017.09.004_bib26","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1016\/j.anai.2010.08.002","article-title":"Drug allergy: an updated practice parameter","volume":"105","author":"Joint Task Force on Practice Parameters; American Academy of Allergy, Asthma and Immunology; American College of Allergy, Asthma and Immunology; Joint Council of Allergy, Asthma and Immunology","year":"2010","journal-title":"Ann Allergy Asthma Immunol"},{"key":"10.1016\/j.jaip.2017.09.004_bib27","first-page":"425","article-title":"Piperacillin-induced DRESS: distinguishing features observed in a clinical and allergy study of 8 patients","volume":"24","author":"Cabanas","year":"2014","journal-title":"J\u00a0Investig Allergol Clin Immunol"},{"key":"10.1016\/j.jaip.2017.09.004_bib28","doi-asserted-by":"crossref","first-page":"442","DOI":"10.1007\/s11882-014-0442-8","article-title":"Skin testing and patch testing in non-IgE-mediated drug allergy","volume":"14","author":"Barbaud","year":"2014","journal-title":"Curr Allergy Asthma Rep"},{"key":"10.1016\/j.jaip.2017.09.004_bib29","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1111\/cod.12720","article-title":"Long-term reproducibility of positive patch test reactions in patients with non-immediate cutaneous adverse drug reactions to antibiotics","volume":"76","author":"Pinho","year":"2017","journal-title":"Contact Dermatitis"},{"key":"10.1016\/j.jaip.2017.09.004_bib30","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1038\/nri.2015.3","article-title":"Tissue-resident memory T cells: local specialists in immune defence","volume":"16","author":"Mueller","year":"2016","journal-title":"Nat Rev Immunol"},{"key":"10.1016\/j.jaip.2017.09.004_bib31","doi-asserted-by":"crossref","first-page":"1095","DOI":"10.1038\/ni1503","article-title":"Mast cell-derived interleukin 10 limits skin pathology in contact dermatitis and chronic irradiation with ultraviolet B","volume":"8","author":"Grimbaldeston","year":"2007","journal-title":"Nat Immunol"},{"key":"10.1016\/j.jaip.2017.09.004_bib32","doi-asserted-by":"crossref","first-page":"350","DOI":"10.1186\/s12879-016-1687-8","article-title":"Accuracy of the interferon-gamma release assay for the diagnosis of active tuberculosis among HIV-seropositive individuals: a systematic review and meta-analysis","volume":"16","author":"Huo","year":"2016","journal-title":"BMC Infect Dis"},{"key":"10.1016\/j.jaip.2017.09.004_bib33","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1186\/s12879-017-2301-4","article-title":"Comparing interferon-gamma release assays with tuberculin skin test for identifying latent tuberculosis infection that progresses to active tuberculosis: systematic review and meta-analysis","volume":"17","author":"Auguste","year":"2017","journal-title":"BMC Infect Dis"},{"key":"10.1016\/j.jaip.2017.09.004_bib34","doi-asserted-by":"crossref","first-page":"1737","DOI":"10.3390\/ijms18081737","article-title":"In\u00a0vitro assays in severe cutaneous adverse drug reactions: are they still research tools or diagnostic tests already?","volume":"18","author":"Porebski","year":"2017","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.jaip.2017.09.004_bib35","doi-asserted-by":"crossref","first-page":"66","DOI":"10.2340\/00015555-1386","article-title":"The potential of using enzyme-linked immunospot to diagnose cephalosporin-induced maculopapular exanthems","volume":"93","author":"Tanvarasethee","year":"2013","journal-title":"Acta Derm Venereol"},{"key":"10.1016\/j.jaip.2017.09.004_bib36","doi-asserted-by":"crossref","first-page":"1372","DOI":"10.1124\/dmd.115.065193","article-title":"In\u00a0vitro hepatic oxidative biotransformation of trimethoprim","volume":"43","author":"Goldman","year":"2015","journal-title":"Drug Metab Dispos"},{"key":"10.1016\/j.jaip.2017.09.004_bib37","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1016\/j.jaci.2009.10.031","article-title":"Stimulation of human T cells with sulfonamides and sulfonamide metabolites","volume":"125","author":"Castrejon","year":"2010","journal-title":"J\u00a0Allergy Clin Immunol"},{"key":"10.1016\/j.jaip.2017.09.004_bib38","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1016\/j.jaci.2005.10.030","article-title":"Long-lasting reactivity and high frequency of drug-specific T cells after severe systemic drug hypersensitivity reactions","volume":"117","author":"Beeler","year":"2006","journal-title":"J\u00a0Allergy Clin Immunol"},{"key":"10.1016\/j.jaip.2017.09.004_bib39","doi-asserted-by":"crossref","first-page":"2223","DOI":"10.1097\/00002030-200211080-00017","article-title":"Utility of patch testing in patients with hypersensitivity syndromes associated with abacavir","volume":"16","author":"Phillips","year":"2002","journal-title":"AIDS"},{"key":"10.1016\/j.jaip.2017.09.004_bib40","doi-asserted-by":"crossref","first-page":"e0117160","DOI":"10.1371\/journal.pone.0117160","article-title":"Abacavir-reactive memory T cells are present in drug naive individuals","volume":"10","author":"Lucas","year":"2015","journal-title":"PLoS One"},{"key":"10.1016\/j.jaip.2017.09.004_bib41","doi-asserted-by":"crossref","first-page":"979","DOI":"10.1097\/01.aids.0000171414.99409.fb","article-title":"Clinical and immunogenetic correlates of abacavir hypersensitivity","volume":"19","author":"Phillips","year":"2005","journal-title":"AIDS"},{"key":"10.1016\/j.jaip.2017.09.004_bib42","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1016\/j.jaci.2015.05.050","article-title":"Evolving models of the immunopathogenesis of T cell-mediated drug allergy: the role of host, pathogens, and drug response","volume":"136","author":"White","year":"2015","journal-title":"J\u00a0Allergy Clin Immunol"},{"key":"10.1016\/j.jaip.2017.09.004_bib43","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1016\/j.jim.2008.01.003","article-title":"Serum-free culture medium and IL-7 costimulation increase the sensitivity of ELISpot detection","volume":"333","author":"Martinuzzi","year":"2008","journal-title":"J\u00a0Immunol Methods"},{"key":"10.1016\/j.jaip.2017.09.004_bib44","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1016\/S0091-6749(03)01624-5","article-title":"IFN-gamma-producing effector CD8+ T cells and IL-10-producing regulatory CD4+ T cells in fixed drug eruption","volume":"112","author":"Teraki","year":"2003","journal-title":"J\u00a0Allergy Clin Immunol"}],"container-title":["The Journal of Allergy and Clinical Immunology: In Practice"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213219817307286?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213219817307286?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T05:16:33Z","timestamp":1761974193000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2213219817307286"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,7]]},"references-count":43,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2018,7]]}},"alternative-id":["S2213219817307286"],"URL":"https:\/\/doi.org\/10.1016\/j.jaip.2017.09.004","relation":{},"ISSN":["2213-2198"],"issn-type":[{"value":"2213-2198","type":"print"}],"subject":[],"published":{"date-parts":[[2018,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The Combined Utility of Ex\u00a0Vivo IFN-\u03b3 Release Enzyme-Linked ImmunoSpot Assay and In\u00a0Vivo Skin\u00a0Testing in Patients with Antibiotic-Associated Severe Cutaneous Adverse Reactions","name":"articletitle","label":"Article Title"},{"value":"The Journal of Allergy and Clinical Immunology: In Practice","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jaip.2017.09.004","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 American Academy of Allergy, Asthma & Immunology","name":"copyright","label":"Copyright"}]}}